Jiankai Liang

Sun Yat-sen University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.1kcitations41works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(33), CAR-T cell therapy research(16), RNA Interference and Gene Delivery(9), Animal Virus Infections Studies(9), Viral Infectious Diseases and Gene Expression in Insects(7)

Publications41 total

Retraction Note: DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
Nature Communications·2025Open Access
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1
Advanced Science·2025Open Access
Reduced oxytocin signaling in the dBNST drives the transition from acute pain to persistent anxiety
Current Biology·2025· 1 cited
HDAC inhibitor MS275 reprograms metabolism to induce differentiation and suppress proliferation in hepatocellular carcinoma
Frontiers in Immunology·2025· 1 citedOpen Access
Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interaction
Nature Communications·2025· 1 citedOpen Access
circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer
Molecular Therapy Oncology·2024Open Access
Arming oncolytic M1 virus with gasdermin E enhances antitumor efficacy in breast cancer
iScience·2024· 6 citedOpen Access
Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8+ T cell activation
Molecular Therapy Oncology·2024· 5 citedOpen Access
Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK‒STAT pathway
Acta Pharmaceutica Sinica B·2024· 7 citedOpen Access
STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M1
Oncogene·2023· 1 cited
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine
Cell Reports Medicine·2023· 23 citedOpen Access
Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile
Nature Communications·2023· 21 citedOpen Access
Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell
Cell Death and Disease·2023· 30 citedOpen Access
Overcoming resistance to oncolytic virus M1 by targeting PI3K-γ in tumor-associated myeloid cells
Molecular Therapy·2022· 12 citedOpen Access
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors
Signal Transduction and Targeted Therapy·2022· 50 citedOpen Access
Correction to: Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells
Virologica Sinica·2021Open Access
Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC
Oncogene·2021· 46 cited
Real-Time Visualization and Quantification of Oncolytic M1 Virus <i>In Vitro</i> and <i>In Vivo</i>
Human Gene Therapy·2021· 15 cited
Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells
Virologica Sinica·2021· 7 citedOpen Access
Suppression of CCDC6 sensitizes tumor to oncolytic virus M1
Neoplasia·2020· 15 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Guangmei Yan(39), Yuan Lin(37), Wenbo Zhu(36), Jing Cai(34), Jun Hu(29), Yaqian Tan(15), Xingwen Su(14), Haipeng Zhang(13), Pengxin Qiu(13), Xiao Xiao(11), Kai Li(10), Wei Yin(10), Fan Xing(10), Xincheng Liu(9), Dan Jia(9), Cheng Hu(9), Jialuo Mai(8), Bingzheng Lu(8), Ying Liu(8), Jiayu Zhang(7)